High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers
Related Posts
Zhao K, Vignolle GA, Labus JS, Mayer EA, Vaughan A, Dy M, Vora P, Hung MW, Vossel K, Gill C, Del Rio D, Stanton C,[...]
It is with great enthusiasm that we announce that Gregory F. Sonnenberg, PhD, has accepted the appointment as director of the UCLA Center for Research[...]
Dunn DP, Dani G, Sharma A, Ioannou GN, Taddei TH, Chang ST, Onyiuke IY, Planeta BM, Huang GD, Weiss NS, Morgan TR, Dominitz JA, Abou-Alfa[...]